EdgarLookup

Jasper Therapeutics, Inc. — 8-K Filings

73 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Jasper Therapeutics, Inc. (JSPRW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Jasper Therapeutics, Inc. has filed 73 8-K documents with the SEC since 2019. To view all SEC filings by Jasper Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 25-NSE 3 3/A 4 424B3 424B4 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP DEF 14A DEFA14A DRS EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-22-025933 May 12, 2022
8-K CURRENT REPORT 0001213900-22-021894 Apr 27, 2022
8-K CURRENT REPORT 0001213900-22-013743 Mar 21, 2022 Mar 17, 2022
8-K CURRENT REPORT 0001213900-22-013584 Mar 18, 2022
8-K CURRENT REPORT 0001213900-22-012935 Mar 16, 2022 Mar 14, 2022
8-K CURRENT REPORT 0001213900-22-012682 Mar 16, 2022
8-K CURRENT REPORT 0001213900-22-011854 Mar 11, 2022 Mar 7, 2022
8-K CURRENT REPORT 0001213900-22-009585 Feb 28, 2022 Feb 25, 2022
8-K CURRENT REPORT 0001213900-22-009272 Feb 25, 2022 Feb 24, 2022
8-K CURRENT REPORT 0001213900-21-058658 Nov 12, 2021
8-K CURRENT REPORT 0001213900-21-055431 Oct 29, 2021 Oct 25, 2021
8-K CURRENT REPORT 0001213900-21-050592 Sep 29, 2021 Sep 24, 2021
8-K CURRENT REPORT 0001213900-21-049423 Sep 23, 2021 Sep 22, 2021
8-K CURRENT REPORT 0001213900-21-048846 Sep 20, 2021
8-K CURRENT REPORT 0001213900-21-047217 Sep 9, 2021
8-K CURRENT REPORT 0001213900-21-027626 May 18, 2021 May 16, 2021
8-K CURRENT REPORT 0001213900-21-025120 May 7, 2021
8-K CURRENT REPORT 0001213900-21-024792 May 6, 2021 May 5, 2021
8-K CURRENT REPORT 0001213900-20-045061 Dec 29, 2020 Dec 22, 2020
8-K CURRENT REPORT 0001213900-20-040662 Dec 3, 2020 Dec 1, 2020
8-K CURRENT REPORT 0001213900-20-000455 Jan 8, 2020 Jan 3, 2020
8-K CURRENT REPORT 0001213900-19-024928 Nov 27, 2019 Nov 22, 2019
8-K CURRENT REPORT 0001213900-19-024606 Nov 25, 2019 Nov 19, 2019